Your browser doesn't support javascript.
loading
Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.
Cheng, Cheng; Wang, Di; Yu, Mingchen; Zhai, You; Pan, Changqing; Liang, Bo; Zhang, Jiazheng; Wang, Chen; Yin, Yiyun; Li, Lianwang; Wu, Fan; Shi, Zhongfang; Fan, Xing; Liu, Xing; Wang, Zhiliang; Zhao, Zheng; Li, Guanzhang; Jiang, Tao; Zhang, Wei.
Afiliação
  • Cheng C; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing , China.
  • Wang D; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing , China.
  • Yu M; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Zhai Y; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Pan C; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing , China.
  • Liang B; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Zhang J; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing , China.
  • Wang C; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing , China.
  • Yin Y; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Li L; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Wu F; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Shi Z; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Fan X; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Liu X; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Wang Z; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing , China.
  • Zhao Z; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Li G; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing , China.
  • Jiang T; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing , China.
  • Zhang W; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing , China.
Neurosurgery ; 93(4): 802-812, 2023 10 01.
Article em En | MEDLINE | ID: mdl-37070826

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Idioma: En Ano de publicação: 2023 Tipo de documento: Article